{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:28:07Z","timestamp":1791908887080,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.vaccine.2022.01.004","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T06:11:01Z","timestamp":1643609461000},"page":"1323-1333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["A scalable, integrated downstream process for production of a recombinant measles virus-vectored vaccine"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0165-8045","authenticated-orcid":false,"given":"Petra","family":"Steppert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Mosor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Stanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9371-1984","authenticated-orcid":false,"given":"Daniel","family":"Burgstaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Palmberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Preinsperger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Pereira Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"M\u00fcllner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Csar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8182-7728","authenticated-orcid":false,"given":"Alois","family":"Jungbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2022.01.004_b0005","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(15)70043-5","article-title":"Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial","volume":"15","author":"Ramsauer","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"16","key":"10.1016\/j.vaccine.2022.01.004_b0010","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1016\/j.vaccine.2007.01.064","article-title":"Attenuated measles virus as a vaccine vector","volume":"25","author":"Zuniga","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2022.01.004_b0015","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s11262-017-1486-3","article-title":"Vaccine platform recombinant measles virus","volume":"53","author":"M\u00fchlebach","year":"2017","journal-title":"Virus Genes"},{"issue":"2","key":"10.1016\/j.vaccine.2022.01.004_b0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/07388551.2019.1709794","article-title":"Opportunities to debottleneck the downstream processing of the oncolytic measles virus","volume":"40","author":"Loewe","year":"2020","journal-title":"Crit Rev Biotechnol"},{"issue":"4","key":"10.1016\/j.vaccine.2022.01.004_b0025","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/14760584.2019.1562908","article-title":"Measles-vectored vaccine approaches against viral infections: a focus on Chikungunya","volume":"18","author":"Gerke","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2022.01.004_b0030","unstructured":"Eriko, Daikoku, Chizuko, Morita, Takehiro, Kohno, et al. Analysis of morphology and infectivity of measles virus particles; 2007."},{"key":"10.1016\/j.vaccine.2022.01.004_b0035","doi-asserted-by":"crossref","DOI":"10.3844\/ajbbsp.2013.243.254","article-title":"Influence of process conditions on measles virus stability","volume":"9","author":"Weiss","year":"2013","journal-title":"Am J Biochem Biotechnol"},{"key":"10.1016\/j.vaccine.2022.01.004_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/membranes9120160","article-title":"Tangential flow filtration for the concentration of oncolytic measles virus: The influence of filter properties and the cell culture medium","volume":"9","author":"Loewe","year":"2019","journal-title":"Membranes"},{"key":"10.1016\/j.vaccine.2022.01.004_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/v11080725","article-title":"Forced degradation studies to identify critical process parameters for the purification of infectious measles virus","volume":"11","author":"Loewe","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2022.01.004_b0050","series-title":"Viral Vectors for Gene Therapy: Methods and Protocols","first-page":"345","article-title":"Manufacture of measles viruses","author":"Langfield","year":"2011"},{"key":"10.1016\/j.vaccine.2022.01.004_b0055","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/ajhp\/61.18.1928","article-title":"USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy","volume":"61","author":"Kastango","year":"2004","journal-title":"Am J Health Syst Pharm"},{"issue":"12","key":"10.1016\/j.vaccine.2022.01.004_b0060","doi-asserted-by":"crossref","first-page":"e115802","DOI":"10.1371\/journal.pone.0115802","article-title":"Evaluation of novel large cut-off ultrafiltration membranes for adenovirus serotype 5 (Ad5) concentration","volume":"9","author":"Nestola","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.01.004_b0065","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.chroma.2013.03.047","article-title":"Purification of infective baculoviruses by monoliths","volume":"1290","author":"Gerster","year":"2013","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.vaccine.2022.01.004_b0070","doi-asserted-by":"crossref","first-page":"461378","DOI":"10.1016\/j.chroma.2020.461378","article-title":"Capture and purification of human immunodeficiency virus-1 virus-like particles: convective media vs porous beads","volume":"1627","author":"Pereira Aguilar","year":"2020","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.vaccine.2022.01.004_b0075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.chroma.2018.12.035","article-title":"Separation of virus-like particles and extracellular vesicles by flow-through and heparin affinity chromatography","volume":"1588","author":"Reiter","year":"2019","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.vaccine.2022.01.004_b0080","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0166-0934(84)90046-6","article-title":"virus: Conditions for the propagation and purification of infectious virus in high yield","volume":"8","author":"Udem","year":"1984","journal-title":"J Virol Methods"},{"issue":"3","key":"10.1016\/j.vaccine.2022.01.004_b0085","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1099\/0022-1317-43-3-633","article-title":"Purification of measles virus with preservation of infectivity and antigenicity","volume":"43","author":"Bellini","year":"1979","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2022.01.004_b0090","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jchromb.2017.04.015","article-title":"Recovery of infective virus particles in ion-exchange and hydrophobic interaction monolith chromatography is influenced by particle charge and total-to-infective particle ratio","volume":"1054","author":"Sviben","year":"2017","journal-title":"J Chromatogr B"},{"issue":"3","key":"10.1016\/j.vaccine.2022.01.004_b0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/elps.1150060302","article-title":"Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining","volume":"6","author":"Heukeshoven","year":"1985","journal-title":"Electrophoresis"},{"key":"10.1016\/j.vaccine.2022.01.004_b0100","series-title":"Virology Methods Manual","first-page":"25","article-title":"2 - Virus isolation and quantitation","author":"Hierholzer","year":"1996"},{"issue":"47","key":"10.1016\/j.vaccine.2022.01.004_b0105","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1016\/j.vaccine.2019.07.001","article-title":"Polymer-grafted chromatography media for the purification of enveloped virus-like particles, exemplified with HIV-1 gag VLP","volume":"37","author":"Pereira Aguilar","year":"2019","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2022.01.004_b0110","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.1128\/JVI.01299-15","article-title":"Double-stranded RNA is detected by immunofluorescence analysis in RNA and DNA virus infections, including those by negative-stranded RNA viruses","volume":"89","author":"Son","year":"2015","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2022.01.004_b0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/hgtb.2012.059","article-title":"Downstream processing of lentiviral vectors: Releasing bottlenecks","volume":"23","author":"Bandeira","year":"2012","journal-title":"Hum Gene Ther Methods"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22000196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22000196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:09:25Z","timestamp":1759403365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22000196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0264410X22000196"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.01.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A scalable, integrated downstream process for production of a recombinant measles virus-vectored vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}